Birdwatch Note
2023-08-28 15:52:06 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Das Long Covid Risiko wurde in der Studie nicht untersucht. Die Aussage "Auch das #LongCovid Risiko sinkt für Geimpfte" ist deshalb im Zusammenhang mit dem neuen Impfstoff eine Irreführung der Leser https://www.medrxiv.org/content/10.1101/2023.08.22.23293434v1 Die Wirksamkeit der Antikörper (z.B. ob IgG4 dabei) wurde nicht geprüft https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222767/
Written by C929EDDD6040B6E311E14F802359E49688212836B260563492C61BD0C65B043F
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1696084235637993664
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1696188920545878241
- noteId - 1696188920545878241
- participantId -
- noteAuthorParticipantId - C929EDDD6040B6E311E14F802359E49688212836B260563492C61BD0C65B043F Participant Details
- createdAtMillis - 1693237926982
- tweetId - 1696084235637993664
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Das Long Covid Risiko wurde in der Studie nicht untersucht. Die Aussage "Auch das #LongCovid Risiko sinkt für Geimpfte" ist deshalb im Zusammenhang mit dem neuen Impfstoff eine Irreführung der Leser https://www.medrxiv.org/content/10.1101/2023.08.22.23293434v1 Die Wirksamkeit der Antikörper (z.B. ob IgG4 dabei) wurde nicht geprüft https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222767/
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-08-28 15:52:06 UTC (1693237926982) |
1969-12-31 23:59:59 UTC (-1) |
2023-08-29 02:11:18 UTC (1693275078609) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-08-28 19:30:21 -0500 | Rating Details | |
2023-08-28 18:21:10 -0500 | Rating Details | |
2023-08-28 17:42:10 -0500 | Rating Details | |
2023-08-28 17:28:26 -0500 | Rating Details | |
2023-08-28 17:17:54 -0500 | Rating Details | |
2023-08-28 17:06:39 -0500 | Rating Details | |
2023-08-28 17:03:41 -0500 | Rating Details | |
2023-08-28 16:35:47 -0500 | Rating Details | |
2023-08-28 16:13:58 -0500 | Rating Details | |
2023-08-28 16:13:55 -0500 | Rating Details | |
2023-08-28 16:06:12 -0500 | Rating Details | |
2023-08-28 15:43:37 -0500 | Rating Details | |
2023-08-28 15:12:39 -0500 | Rating Details | |
2023-08-28 14:54:41 -0500 | Rating Details | |
2023-08-28 14:39:56 -0500 | Rating Details | |
2023-08-28 14:31:22 -0500 | Rating Details | |
2023-08-28 14:25:54 -0500 | Rating Details | |
2023-08-28 14:14:49 -0500 | Rating Details | |
2023-08-28 14:02:18 -0500 | Rating Details | |
2023-08-28 13:57:55 -0500 | Rating Details | |
2023-08-28 13:55:35 -0500 | Rating Details | |
2023-08-28 13:34:50 -0500 | Rating Details | |
2023-08-28 13:23:02 -0500 | Rating Details | |
2023-08-28 13:11:27 -0500 | Rating Details | |
2023-08-28 13:11:16 -0500 | Rating Details | |
2023-08-28 13:06:21 -0500 | Rating Details | |
2023-08-28 12:56:37 -0500 | Rating Details | |
2023-08-28 12:45:15 -0500 | Rating Details | |
2023-08-28 12:33:49 -0500 | Rating Details | |
2023-08-28 12:25:57 -0500 | Rating Details | |
2023-08-28 12:24:15 -0500 | Rating Details | |
2023-08-28 12:21:13 -0500 | Rating Details | |
2023-08-28 12:05:40 -0500 | Rating Details | |
2023-08-28 12:04:20 -0500 | Rating Details | |
2023-08-28 12:00:43 -0500 | Rating Details | |
2023-08-28 11:49:04 -0500 | Rating Details | |
2023-08-28 11:47:27 -0500 | Rating Details | |
2023-08-28 11:46:52 -0500 | Rating Details | |
2023-08-28 11:44:14 -0500 | Rating Details | |
2023-08-28 11:40:04 -0500 | Rating Details | |
2023-08-28 11:36:10 -0500 | Rating Details | |
2023-08-28 11:29:42 -0500 | Rating Details | |
2023-08-28 11:11:10 -0500 | Rating Details | |
2023-08-28 10:59:07 -0500 | Rating Details | |
2023-08-28 10:57:04 -0500 | Rating Details | |
2023-08-29 09:06:05 -0500 | Rating Details | |
2023-08-29 05:43:13 -0500 | Rating Details | |
2023-08-29 05:33:35 -0500 | Rating Details | |
2023-08-29 03:46:37 -0500 | Rating Details | |
2023-08-29 03:31:26 -0500 | Rating Details | |
2023-08-29 02:40:14 -0500 | Rating Details | |
2023-08-29 02:33:36 -0500 | Rating Details | |
2023-08-29 02:10:58 -0500 | Rating Details | |
2023-08-29 02:04:21 -0500 | Rating Details | |
2023-08-29 01:31:02 -0500 | Rating Details | |
2023-08-29 01:03:03 -0500 | Rating Details | |
2023-08-29 00:38:54 -0500 | Rating Details | |
2023-08-29 00:22:56 -0500 | Rating Details | |
2023-08-28 23:58:04 -0500 | Rating Details | |
2023-08-28 22:19:47 -0500 | Rating Details | |
2023-08-28 22:09:51 -0500 | Rating Details | |
2023-08-28 20:57:33 -0500 | Rating Details | |
2023-08-28 20:27:53 -0500 | Rating Details | |
2023-08-31 14:51:55 -0500 | Rating Details | |
2023-08-31 08:22:00 -0500 | Rating Details | |
2023-09-12 04:21:10 -0500 | Rating Details | |
2023-10-03 01:49:40 -0500 | Rating Details |